Stockreport

Century Therapeutics to Participate in Upcoming Investor Conferences in March

Century Therapeutics, Inc.  (IPSC) 
PDF PHILADELPHIA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell [Read more]